Novellia Snags $18M for Its Real-World Data Platform
Novellia raised $18 million in Series A funding to enhance its real-world data platform, aimed at consolidating patient medical records and facilitating the sharing of anonymized data with pharmaceutical companies. CEO Shashi Shankar emphasized that sourcing data directly from patients can lead to more comprehensive healthcare datasets and improve drug research outcomes.The Deal
Novellia's Series A funding round secured $18 million from various investors, although specific names have not been disclosed. This capital will be utilized to scale their innovative platform, which focuses on empowering patients to manage and share their healthcare data.What It Means for RCM
- The increased availability of real-world data could enhance clinical decision-making and reduce denial rates, as payers may rely more on comprehensive datasets for coverage determinations.
- Billing teams may need to adapt workflows to accommodate new data-sharing requirements and processes, potentially impacting days in AR as data is integrated and validated.
- This funding may spur competition in the vendor landscape, challenging existing RCM solutions to incorporate real-world data into their offerings.
Market Context
The healthcare RCM landscape is seeing a surge in funding aimed at technology-driven solutions, particularly those leveraging artificial intelligence and real-world data. As healthcare organizations increasingly prioritize data integration and patient engagement, investments like Novellia's Series A funding reflect a broader trend toward enhancing data accessibility and improving outcomes in healthcare delivery. This funding round highlights the growing recognition that more complete datasets can lead to significant advancements in patient care and operational efficiencies.Free Daily RCM Intelligence
Denial trends, payer policy moves, vendor intel — delivered every morning. Free.